Alport syndrome is a hereditary disorder of the basement membrane that causes glomerulopathy that causes progressive renal failure, which can variably be associated with decreased hearing of neurosensory origin as well as different ocular manifestations. Maculopathy, mainly described in patients with X-linked Alport syndrome, is characterized by whitish or yellowish spots in the perimacular region.
This service is recommended when, during an ophthalmological examination, a characteristic image of the fundus of the eye is detected together with the other ocular, auditory, or mainly renal manifestations, a previously undiagnosed Alport syndrome was suspected.
1) Download & fill out
Please cover as many fields as possible in both documents
2) Sample collection
See sample types in the guidelines
3) Pack the sample
Please pack the sample in a way to prevent leakage
4) Send the sample & the request
Please schedule the delivery for Monday–Friday: 8am – 5pm
5) Result: the report
Via: e-mail and/or through the customer portal
"*" indicates required fields
Turnaround time (TAT):
Ref. S-201906489
Virtual panel based on whole exome sequencing, aimed at the analysis of all Alport syndrome genes.
Priority Genes : Genes where there is sufficient evidence (clinical and functional) to consider them associated with the disease; they are included in the clinical practice guidelines.
Secondary Genes: Genes related to the disease, but with a lower level of evidence or that constitute sporadic cases.
* Candidate Genes: Not enough evidence in humans, but potentially associated with the disease.
Maculopathy associated with Alport syndrome.
